SINGAPORE, May 14, 2025 /PRNewswire/ -- The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive ...

SINGAPORE, May 14, 2025 /PRNewswire/ -- The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive ...

Following these encouraging results from APG990, we are advancing our first-in-class combination strategy with plans to initiate a head-to-head Phase 1b study of APG279 versus DUPIXENT in AD ... or ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria (CSU), a condition that causes painful hives that often don't respond to ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

“But, it's exciting to get an injection of youth to go along with a lot of the veterans that we have on this football team. So, it's exciting. It's going to be fun to work with them.” The ...

The This Morning star, 50, admitted she was initially scared of using weight loss injections after learning more about them. She feels that perhaps they are not the right option for her at this ...

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role beyond simply helping people shed pounds. This may be because weight loss jabs ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

The extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.

Managing chronic conditions like allergies and eczema can be challenging. Dupixent (dupilumab) has become an important treatment for many people suffering from these conditions. However, the cost of ...